Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.
Open | $2.141 |
Close | $2.330 |
Volume / Avg. | 173.935K / 83.305K |
Day Range | 2.141 - 2.500 |
52 Wk Range | 1.550 - 5.410 |
Market Cap | $20.006M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 0.59% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alterity Therapeutics (NASDAQ: ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Dominari Holdings (NASDAQ:DOMH) and Addex Therapeutics (NASDAQ:ADXN).
The latest price target for Alterity Therapeutics (NASDAQ: ATHE) was reported by Benchmark on Thursday, March 7, 2024. The analyst firm set a price target for 4.00 expecting ATHE to rise to within 12 months (a possible 74.55% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $2.2916 last updated April 24, 2024 at 7:13 PM EDT.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.